Massimo Gagliardi
Overview
Explore the profile of Massimo Gagliardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramadan M, Boccia F, Moretto S, De Gregorio F, Gagliardi M, Iossa D, et al.
J Clin Med
. 2022 Oct;
11(19).
PMID: 36233646
Background: Chronic hepatitis C (CHC) is associated with hepatic and extrahepatic complications, including cardiovascular disease (CVD). The effects of sustained virological response (SVR) and liver fibrosis on CVD risk are...
2.
Bertolino L, Patauner F, Gagliardi M, DAmico F, Crivaro V, Bernardo M, et al.
Infez Med
. 2021 Mar;
29(1):70-78.
PMID: 33664175
Clostridioides difficile (CD) is a major nosocomial pathogen and the leading cause of antibiotic-associated diarrhoea. In light of the strong association between antimicrobial use and CD infections (CDI), it may...
3.
Karruli A, Spiezia S, Boccia F, Gagliardi M, Patauner F, Salemme A, et al.
Transpl Infect Dis
. 2021 Feb;
23(4):e13595.
PMID: 33641202
Background: The aim of this study was to assess the effect of continuing immune suppressive therapy in solid organ transplant recipients (SOTR) with coronavirus disease 2019 (COVID-19). Methods: Systematic review...
4.
Karruli A, Boccia F, Gagliardi M, Patauner F, Ursi M, Sommese P, et al.
Microb Drug Resist
. 2021 Feb;
27(9):1167-1175.
PMID: 33600262
The aim of this study was to assess the drivers of multidrug-resistant (MDR) bacterial infection development in coronavirus disease 2019 (COVID-19) and its impact on patient outcome. Retrospective analysis on...
5.
Iossa D, Vitrone M, Gagliardi M, Falco E, Ragone E, Zampino R, et al.
Ann Transl Med
. 2021 Feb;
9(1):35.
PMID: 33553328
Background: Hepatitis C virus (HCV) infection affects lipid metabolism. We investigated the impact of direct-acting antiviral (DAA) treatment on lipid metabolism in chronic hepatitis C (CHC), with a focus on...
6.
Di Mauro M, Iaco A, Di Lorenzo C, Gagliardi M, Varone E, Al Amri H, et al.
Eur J Cardiothorac Surg
. 2012 Jun;
43(1):168-73.
PMID: 22648926
Objectives: To identify a safety threshold of deep hypothermic circulatory arrest (DHCA) duration; to determine which protection offers the best outcome and whether a 10-min period of cold perfusion (20°C)...
7.
Mazzei V, Benvenuto D, Gagliardi M, Guarracini S, Di Mauro M
J Card Surg
. 2011 Sep;
26(6):617-8.
PMID: 21929740
A 71-year-old female developed a painless neck mass three months following an aortic valve replacement, mitral commissurotomy, and coronary artery bypass. A cervical trunk angio revealed a pseudoaneurysm supplied from...
8.
Di Mauro M, Contini M, Iaco A, Bivona A, Gagliardi M, Varone E, et al.
J Thorac Cardiovasc Surg
. 2009 Mar;
137(4):869-74.
PMID: 19327510
Objective: This study was undertaken to evaluate long-term results of bilateral internal thoracic artery grafting with saphenous vein or another arterial conduit as the third conduit. Methods: From September 1991...
9.
Mitral valve surgery for functional mitral regurgitation: prognostic role of tricuspid regurgitation
Di Mauro M, Bivona A, Iaco A, Contini M, Gagliardi M, Varone E, et al.
Eur J Cardiothorac Surg
. 2009 Feb;
35(4):635-9.
PMID: 19233670
Background: The purpose of this study was to evaluate the impact of untreated moderate-or-more functional tricuspid regurgitation (FTR) on mid-term outcome of patients with functional mitral regurgitation (FMR) undergoing mitral...
10.
Calafiore A, Gallina S, Iaco A, Contini M, Bivona A, Gagliardi M, et al.
Ann Thorac Surg
. 2009 Feb;
87(3):698-703.
PMID: 19231373
Background: The aim of this retrospective study was to evaluate the clinical outcome of treating or not treating moderate-or-more functional tricuspid regurgitation in patients with functional mitral regurgitation undergoing mitral...